STOCK TITAN

Fidelis Insurance (NYSE: FIHL) director receives 6,517 restricted share units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Fidelis Insurance Holdings Ltd director equity grant: Director Collis Charles Grant Ross received an award of 6,517 common shares in the form of restricted share units at a price of $0.00 per share as compensation. These RSUs are subject to time-based vesting, and each unit converts into one common share upon vesting. Following this award, Ross directly holds 11,948 common shares, reflecting a routine, non‑market equity compensation grant rather than an open‑market purchase.

Positive

  • None.

Negative

  • None.
Insider Collis Charles Grant Ross
Role Director
Type Security Shares Price Value
Grant/Award Common Shares 6,517 $0.00 --
Holdings After Transaction: Common Shares — 11,948 shares (Direct)
Footnotes (1)
  1. [object Object]
RSU grant size 6,517 shares Restricted share units awarded to director
Grant price $0.00 per share Equity compensation, not market purchase
Total shares after grant 11,948 shares Director’s direct holdings following transaction
restricted share units financial
"Includes 6,517 restricted share units ("RSUs") subject to time-based vesting conditions."
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
time-based vesting conditions financial
"RSUs subject to time-based vesting conditions."
contingent right financial
"Each RSU represents a contingent right to receive one common share upon vesting."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Collis Charles Grant Ross

(Last)(First)(Middle)
WELLESLEY HOUSE SOUTH
90 PITTS BAY ROAD

(Street)
PEMBROKEHM08

(City)(State)(Zip)

BERMUDA

(Country)
2. Issuer Name and Ticker or Trading Symbol
Fidelis Insurance Holdings Ltd [ FIHL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares03/30/2026A6,517A$011,948(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes 6,517 restricted share units ("RSUs") subject to time-based vesting conditions. Each RSU represents a contingent right to receive one common share upon vesting.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Ida A. Nizankowska-Polus, Attorney-in-Fact04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Fidelis Insurance (FIHL) report in this Form 4?

Fidelis Insurance reported that director Collis Charles Grant Ross received 6,517 restricted share units as an equity award. The grant is compensation-based, carries a $0.00 grant price, and increases his direct common share holdings to 11,948 after the transaction.

Was the Fidelis Insurance (FIHL) Form 4 transaction a market purchase or sale?

The transaction was not a market trade. It was a grant of 6,517 restricted share units at $0.00 per share as compensation. No open-market buying or selling occurred, making this a routine equity award rather than a discretionary investment decision.

How do the 6,517 RSUs granted to the FIHL director work?

The 6,517 RSUs represent a contingent right to receive one Fidelis common share per unit. They are subject to time-based vesting conditions, meaning the director receives actual shares only as the vesting schedule is satisfied over time.

What are the director’s total FIHL holdings after this Form 4 transaction?

After receiving the 6,517 restricted share units, director Collis Charles Grant Ross directly holds 11,948 Fidelis common shares. This total reflects his post-transaction position and includes the newly awarded units as described in the filing footnote.

Does the Fidelis Insurance (FIHL) RSU grant affect cash for the director or company?

The RSU grant itself involves no cash payment by the director, with a grant price of $0.00 per share. It represents non-cash equity compensation, delivering future shares upon vesting under the specified time-based conditions in the award.